Summarised useful information on SIN – listed Reits 26 Nov 10 – Part 1 Short NameCurLast PriceAnalyst Consensus PxChg from consensus TP52 Wk High52 Wk LowAdj Mkt Cap (S$m) First…
read moreSummarised useful info on STI component stocks dated 26 Nov 10 – Part 1 Short NameCurLast PriceAnalyst Consensus PxChg from consensus TP52 Wk High52 Wk LowAdj Mkt Cap (S$m) Singapore…
read morePursuant to the write-up on Broadway on 2 Nov 10, Broadway has slid to $0.985 in line with the weak market. I have mentioned that $1.01 and $0.935 are major…
read moreBroadway released a set of results, slightly below consensus estimates, causing the share price to slump 9% as at Friday. Nevertheless, if one looks at the analyst target price (Figure…
read moreSummarised useful information on SIN – listed Reits 16 Nov 10 – Part 1 Short NameCurLast PriceAnalyst Consensus PxChg from consensus TP52 Wk High52 Wk LowAdj Mkt Cap (S$m) First…
read moreSummarised useful info on STI component stocks dated 16 Nov 10 – Part 1 Short NameCurLast PriceAnalyst Consensus PxChg from consensus TP52 Wk High52 Wk LowAdj Mkt Cap (S$m) Singapore…
read moreCSE posted a good set of 3QFY10 results on 11 Nov, after the close of trade. Revenue rose 7% from $102M in 3QFY09 to $109M in 3QFY10. Net profit rose 19%…
read moreFuxing China (“Fuxing”) piques my interest as analysts have ascribed an average target price of $0.27 which last traded at $0.16. This represents a whopping 69% potential upside. Dividend yield…
read more3QFY10 Results Revenue rose 50% from RMB128M in 3QFY09 to RMB192M in 3QFY10. NPAT surged 54% from RMB25M in 3QFY09 to RMB39M in 3QFY10. EPS rose 54% from 9.5 RMB…
read more